BML-284 NEW
| Price | $55 | $80 | $143 |
| Package | 5mg | 10mg | 25mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-11-10 |
Product Details
| Product Name: BML-284 | CAS No.: 853220-52-7 |
| Purity: 99.92% | Supply Ability: 10g |
| Release date: 2025/11/10 |
Product Introduction
Bioactivity
| Name | BML-284 |
| Description | BML-284 (Wnt agonist 1) is a potent, selective and , cell-permeable Wnt signaling activator. |
| In vitro | Wnt agonist 1 does not inhibit the activity of GSK-3β, and may be a useful tool in the study of physiological processes that involve the Wnt pathway. [1] |
| In vivo | In a Xenopus model, Wnt agonist 1 (10 μM) mimics the effects of Wnt at the whole-organism level, and affects Xenopus embryonic head specification. [1] |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | H2O : < 1 mg/mL (insoluble or slightly soluble) 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (5.71 mM), Sonication is recommended. Ethanol : < 1 mg/mL (insoluble or slightly soluble) DMSO : 75 mg/mL (214.06 mM), Sonication is recommended. |
| Keywords | βcatenin | Wnt/β-catenin | Wnt/betacatenin | Wnt/b-catenin | Wnt | TCF | N-cadherin | MNK45 | malformed phenotype | Inhibitor | inhibit | E-cadherin | cardiac defect | BML-284 | BML284 | BML 284 | beta-catenin | betacatenin | bcatenin | AGS |
| Inhibitors Related | Urea | PRI-724 | Wnt pathway activator 1 | TNIK-IN-3 | L-quebrachitol | EMT inhibitor-1 | CHIR-99021 | XAV-939 | TNIK-IN-2 | Nefopam hydrochloride | KY-05009 | Bisdemethoxycurcumin |
| Related Compound Libraries | Neural Regeneration Compound Library | Bioactive Compound Library | Cancer Cell Differentiation Compound Library | Anti-Cancer Metabolism Compound Library | Anti-Obesity Compound Library | Anti-Ovarian Cancer Compound Library | Neuroprotective Compound Library | Anti-Fibrosis Compound Library | Stem Cell Differentiation Compound Library | Bioactive Compounds Library Max | Cytoskeletal Signaling Pathway Compound Library | Anti-Liver Cancer Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $493.00/2mg |
VIP4Y
|
TargetMol Chemicals Inc.
|
2025-07-18 | |
| $2380.00/50mg |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-07-21 | |
| $32.00/25kg |
VIP7Y
|
Jinan Finer Chemical Co., Ltd
|
2022-03-18 | |
| $1.00/1g |
VIP6Y
|
Career Henan Chemical Co
|
2019-12-23 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY